Alnylam Pharmaceuticals (ALNY) Shareholder's Equity (QoQ) (2010 - 2026)
Alnylam Pharmaceuticals (ALNY) Shareholder's Equity (QoQ) (2010 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Alnylam Pharmaceuticals |
37.04 Bn |
34.03 Bn |
959.66 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
36.27% |
| Dec 31, 2025 |
237.41% |
| Sep 30, 2025 |
-6.66% |
| Jun 30, 2025 |
-41.20% |
| Mar 31, 2025 |
535.20% |
| Dec 31, 2024 |
107.36% |
| Sep 30, 2024 |
1,154.91% |
| Jun 30, 2024 |
98.60% |
| Mar 31, 2024 |
0.62% |
| Dec 31, 2023 |
-33.03% |
| Sep 30, 2023 |
59.36% |
| Jun 30, 2023 |
-57.43% |
| Mar 31, 2023 |
-63.84% |
| Dec 31, 2022 |
-133.93% |
| Sep 30, 2022 |
-138.42% |
| Jun 30, 2022 |
-56.12% |
| Mar 31, 2022 |
-31.80% |
| Dec 31, 2021 |
-22.18% |
| Sep 30, 2021 |
-11.42% |
| Jun 30, 2021 |
-7.86% |
